Articles from Confluent Medical Technologies

Confluent Unveils Material Breakthrough That Delivers Twice The Strength Of Traditional Polyimide

SCOTTSDALE, Ariz., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent) announced today that Dean Schauer, who has served as the company’s Chief Executive Officer for more than a decade, has assumed the role of Chairman in addition to his existing responsibilities as CEO and President.

SCOTTSDALE, Ariz., March 08, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, a leading materials science platform that supports the design, development and manufacturing of life saving implants, today announced the appointments of Sandy Stojkovski, Chief Executive Officer, North America of Vitesco Technologies, and Brian Yoor, former Chief Financial Officer of Abbott, to its Board of Directors.

Confluent Becomes ATI’s Fulfillment Partner for Medical Nitinol

Confluent Medical Technologies Announces The Launch Of Their New Polymer Webshop Offering 1-2 Day Lead Times

Confluent Now Offers Polyimide Tubing That Complies With REACH And EU Regulations

Confluent Medical Technologies (Confluent), today announced the Grand Opening of the latest addition to their large scale manufacturing center of excellence in Alajuela, Costa Rica, expanding their capacity for Nitinol processing and catheter manufacturing.

Confluent Medical Technologies (“Confluent”), a leading materials science, development, and manufacturing partner to medical device manufacturers, today announced the closing of a majority investment from TPG Capital, the private equity platform of alternative asset management firm TPG.

Confluent Medical Technologies (“Confluent”), a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), today announced that TPG Capital, the private equity platform of alternative asset management firm TPG, has agreed to make a majority investment in the company. TPG Capital joins existing investor Ampersand Capital Partners (“Ampersand”), which will retain a substantial minority interest in Confluent.

Confluent Medical Technologies (“Confluent”) announces today that their new High Precision Polymer Tuber center of excellence is offering lead times of 4 weeks or less.

Confluent Medical Technologies (“Confluent”) announces today the official opening of their Chattanooga, Tenn., Specialty Polymer Tubing center of excellence.

Confluent Medical Technologies (Confluent), today announced a significant expansion of their Costa Rica manufacturing by adding a new facility to accommodate the increase in customer demand for specialized medical devices utilizing Nitinol components and complex catheters.